TLR agonists induce the differentiation of human bone marrow CD34+ progenitors into CD11c+ CD80/86+ DC capable of inducing a Th1‐type response
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
We recently reported that human bone marrow hematopoietic CD34+ progenitors express functional Toll‐like receptors (TLR) and can differentiate into myeloid cells just by stimulation with resiquimod (R848), a specific agonist for TLR7/8. However, the mechanisms by which R848 induces cell differentiation, the effects of other TLR agonists and the functionality of the differentiated cells are not known. Comparable to R848, loxoribine (a TLR7 agonist) and Pam 3 CSK 4 (a TLR2 agonist) induced cytokine production and cell differentiation along the myeloid lineage. R848 and loxoribine were more effective than Pam 3 CSK 4 at inducing the lineage‐negative (CD11c+ CD14–) dendritic cells (DC), whereas Pam 3 CSK 4 was more effective at inducing CD11c+ CD14+ monocytes. Both cell subsets expressed CD80/CD86 and HLA‐DR molecules; however, they showed differential expression of CD1a, CD1b, CD1c, CD11b, CD206 and CD207 markers when compared with each other. Cell differentiation into DC was significantly inhibited by an anti‐TNF‐α nonoclonal antibody. The CD11c+ CD14– subset was isolated and shown to be more potent in stimulating an alloreaction than the CD11c+ CD14+ subset. Collectively, these data highlight the differential effects of TLR agonists on human bone marow CD34+ progenitor cells and provide a new opportunity for generating functional DC that would be useful in cancer vaccination.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Negative regulation of Toll-like receptor-mediated immune responses
Liew, F. Y., Xu, D., Brint, E. K., & O'Neill, L. A. J. (2005) · Nature Reviews Immunology · doi:10.1038/nri1630 · Cited by 1,509
Chemokines: key players in innate and adaptive immunity
Esche, C., Stellato, C., & Beck, L. A. (2005) · Journal of Investigative Dermatology · doi:10.1111/j.0022-202x.2005.23841.x · Cited by 385
Cited by
Merad, M., Sathe, P., Helft, J., Miller, J., & Mortha, A. (2013) · Annual Review of Immunology · doi:10.1146/annurev-immunol-020711-074950 · Cited by 2,309
Manz, M. G., & Boettcher, S. (2014) · Nature Reviews Immunology · doi:10.1038/nri3660 · Cited by 855
Demand-adapted regulation of early hematopoiesis in infection and inflammation
Takizawa, H., Boettcher, S., & Manz, M. G. (2012) · Blood · doi:10.1182/blood-2011-12-380113 · Cited by 410
Inflamm-aging of hematopoiesis, hematopoietic stem cells, and the bone marrow microenvironment
Kovtonyuk, L. V., Fritsch, K., Feng, X., Manz, M. G., & Takizawa, H. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00502 · Cited by 371
“, IL-1b, IL-6, IL-8, TNF-α, and GM-CSF, as well as cell differentiation of the myeloid lineage (122, 123).”
BackgroundInflammatory signals regulate hematopoietic stem cells
Baldridge, M. T., King, K. Y., & Goodell, M. A. (2011) · Trends in Immunology · doi:10.1016/j.it.2010.12.003 · Cited by 339
Metadata
- Authors
- Sioud, M., & Fløisand, Y.
- Venue
- European Journal of Immunology
- Publisher
- Wiley
- Published
- 2007-09-26
- Volume
- 37
- Issue
- 10
- Pages
- 2834-2846
- ISSN
- 0014-2980 (ISSN-L)
- 1521-4141
- OpenAlex
- W2050628678
- Cited by
- 83
- References
- 2
- FWCI
- 1.43
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.